Defervescence Period Of Azithromycin Versus Ceftriaxone In

Authors: Aziz Langah , Muhammad Nadeem Chohan, Abdul Hameed Radhan

1 Peoples Women Medical University, Shaheed Benazir Abad. Sindh
2 LUMHS, Jamshoro. Sindh.
3 Indus Medical College, Tando Muhammad Khan Sindh

Volume 24 | Issue 1

Published: October 29, 2026

Abstract

To compare the defervescence period of azithromycin versus ceftriaxone in children with enteric fever Study Design: Randomised Controlled trial. Setting And Duration: Department of Paediatrics, Federal Government Polyclinic (PGMI), Islamabad. 6 months from 30th June 2014 till 30th December 2014. Subjects: 100 patients: 50 in each respective treatment group i.e. Group A (Azithromycin) and Group B (Ceftriaxone). Method: Out of the 100 patients, 50 placed in Group A were randomly assigned to receive oral azithromycin suspension/capsule (10mg/kg/day; maximum dose, 500mg/day) administered once daily for 7 days and Group B with Intravenous (I/V) ceftriaxone (75mg/ kg/day; maximum dose, 2.5 g/day) administered twice daily for 10 days. The Clinical response to the therapy of both drugs was calculated in terms of number of days taken for defervescence. Results: Patients on Azithromycin had the mean time of defervescence 4.08 days ± S.D 0.922 and for patients on ceftriaxone; mean time of defervescence was 4.06 days ± S.D 1.038. There was no statistically significant difference (p=0.919) between the two groups, thus signifying equal efficacy of both drugs. Conclusion: Oral Azithromycin and Intravenous Ceftriaxone are equal in efficacy, for the treatment of Enteric Fever in children. Azithromycin could be a suitable alternative owing to its convenient dosing, which could be monitored on outpatient basis.

Keywords: Typhoid fever, enteric fever, Ceftriaxone, Azithromycin, efficacy, treatment outcome

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Children With Enteric Fever